H. Kim

Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells With Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT

Jooyoung Lee, Hyosil Kim, Jae Eun Lee et al. · Gastroenterology · 2018 · 122 citations · Full text

Medicine, Oncology, Pharmacology +17

Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities

Sejin Oh, Jeonghun Yeom, Hee Jin Cho et al. · Nature Communications · 2020 · 100 citations · Full text

Medicine, Cancer Biology, Oncology +17

Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy

S-M Kim, H. Kim, Hye Ryun Kim et al. · Oncogenesis · 2016 · 61 citations · Full text

Medicine, Oncology, Pharmacology +17

Improvement in skin wrinkles from the use of photostable retinyl retinoate: a randomized controlled trial

H. Kim, N. Kim, Sungyong Jung et al. · British Journal of Dermatology · 2009 · 31 citations

Medicine, Dermatology, Pharmacology +7

Serum neuron-specific enolase as an early predictor of delayed neuropsychiatric sequelae in patients with acute carbon monoxide poisoning

H. Kim, H. Kim, HI Kim et al. · Human & Experimental Toxicology · 2017 · 25 citations

Pharmacy, Neurology, Neuroscience +15